2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Lundbeckfond Invest A/S | 10% Owner | 7,901,234 | Aug 11, 2023 |
| Kurma Partners | — | 6,821,133 | Aug 21, 2023 |
| Novo A/S | 10% Owner | 4,354,449 | Jul 26, 2024 |
| Vivo Opportunity, LLC | 10% Owner | 3,015,545 | Aug 10, 2023 |
| Vivo Opportunity Fund Holdings, L.P. | 10% Owner | 3,015,545 | Aug 10, 2023 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | Jun 6, 2025 | Smith David V | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | Hunter Heidi | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | Hirth Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | Glaub Kathleen Sereda | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | Elling Christian E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | Collins Helen Louise | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 30, 2025 | Jun 2, 2025 | Hunter Heidi | Director | Buy | 91.3 | +15,000 | 100.00% | ✗ | $20.9K |
| Apr 2, 2025 | Apr 4, 2025 | Zocca Mai-Britt | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 2, 2025 | Apr 4, 2025 | Sullivan Amy | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 2, 2025 | Apr 4, 2025 | Smith Devin Whittemore | General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 2, 2025 | Apr 4, 2025 | Burkavage Brian | Chief Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 2, 2025 | Apr 4, 2025 | Ahmad Qasim Iftikhar | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 23, 2024 | Dec 26, 2024 | Ahmad Qasim Iftikhar | Chief Medical Officer | Buy | 91.3 | +31,350 | 100.00% | ✗ | $26.6K |
| Dec 23, 2024 | Dec 23, 2024 | Zocca Mai-Britt | CEO | Buy | 91.3 | +12,500 | 19.54% | ✗ | $10.1K |
| Dec 23, 2024 | Dec 23, 2024 | Sullivan Amy | CFO | Buy | 90.0 | +10,250 | 13.78% | ✗ | $8.5K |
| Dec 23, 2024 | Dec 23, 2024 | Smith Devin Whittemore | General Counsel | Buy | 90.0 | +12,000 | 243.01% | ✗ | $9.7K |
| Jul 25, 2024 | Jul 26, 2024 | Novo Holdings A/S | 10% Owner | Sell | 22.5 | -75,000 | -1.69% | ✗ | $99.1K |
| Jun 6, 2024 | Jun 7, 2024 | Smith David V | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | Hunter Heidi | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | Hirth Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | Glaub Kathleen Sereda | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | Elling Christian E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | Collins Helen Louise | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 10, 2024 | May 14, 2024 | Novo Holdings A/S | 10% Owner | Sell | 20.0 | -658,809 | -12.95% | ✗ | $802.5K |
| Mar 15, 2024 | Mar 18, 2024 | Zocca Mai-Britt | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 15, 2024 | Mar 18, 2024 | Sullivan Amy | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 15, 2024 | Mar 18, 2024 | Smith Devin Whittemore | General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 15, 2024 | Mar 18, 2024 | Burkavage Brian | Chief Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 15, 2024 | Mar 18, 2024 | Ahmad Qasim Iftikhar | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 9, 2024 | Feb 13, 2024 | Novo Holdings A/S | 10% Owner | Sell | 20.0 | -658,809 | -11.46% | ✗ | $988.4K |
| Nov 21, 2023 | Nov 24, 2023 | Burkavage Brian | Chief Accounting Officer | Buy | 91.3 | +10,000 | 666.67% | ✗ | $10.1K |
| Nov 15, 2023 | Nov 17, 2023 | Collins Helen Louise | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 17, 2023 | Collins Helen Louise | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 21, 2023 | Kurma Partners | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 11, 2023 | Aug 15, 2023 | Hunter Heidi | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 15, 2023 | Hunter Heidi | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 9, 2023 | Aug 11, 2023 | Elling Christian E | Director | Neutral | 90.0 | +7,901,234 | 130.61% | ✗ | - |
| Aug 9, 2023 | Aug 11, 2023 | Lundbeckfond Invest A/S | Director | Neutral | 90.0 | +7,901,234 | 130.61% | ✗ | - |
| Aug 9, 2023 | Aug 11, 2023 | Novo Holdings A/S | 10% Owner | Buy | 100.0 | +2,469,135 | 76.25% | ✗ | $5M |
| Aug 9, 2023 | Aug 10, 2023 | Vivo Capital IX, LLC | 10% Owner | Buy | 100.0 | +3,157,894 | 104.72% | ✗ | $6M |
| Aug 9, 2023 | Aug 9, 2023 | Zocca Mai-Britt | CEO | Neutral | 90.0 | +37,037 | 137.51% | ✗ | - |
| Aug 9, 2023 | Aug 9, 2023 | Sullivan Amy | CFO | Neutral | 90.0 | +49,382 | 197.53% | ✗ | - |
| Aug 9, 2023 | Aug 9, 2023 | Smith Devin Whittemore | General Counsel | Neutral | 90.0 | +4,938 | 100.00% | ✗ | - |
| Jul 17, 2023 | Jul 19, 2023 | Ahmad Qasim Iftikhar | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 19, 2023 | Ahmad Qasim Iftikhar | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 8, 2023 | Jun 13, 2023 | Smith David V | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2023 | Jun 13, 2023 | Nielsen Jack | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2023 | Jun 13, 2023 | Hirth Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2023 | Jun 13, 2023 | Glaub Kathleen Sereda | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2023 | Jun 13, 2023 | Elling Christian E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 20, 2023 | Mar 22, 2023 | Al-Hajj Muhammad | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 20, 2023 | Mar 22, 2023 | Zocca Mai-Britt | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 20, 2023 | Mar 22, 2023 | Sullivan Amy | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 20, 2023 | Mar 22, 2023 | Burkavage Brian | Chief Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 20, 2023 | Mar 22, 2023 | Ehrnrooth Eva | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 17, 2023 | Mar 20, 2023 | Sullivan Amy | CFO | Buy | 95.0 | +25,000 | 100.00% | ✗ | $58K |
| Jan 12, 2023 | Jan 13, 2023 | Smith Devin Whittemore | General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 13, 2023 | Smith Devin Whittemore | General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 17, 2022 | Oct 19, 2022 | Sullivan Amy | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 19, 2022 | Sullivan Amy | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| May 31, 2022 | Jun 2, 2022 | Burkavage Brian | Chief Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 26, 2022 | May 31, 2022 | Hirth Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 26, 2022 | May 31, 2022 | Smith David V | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 26, 2022 | May 31, 2022 | Glaub Kathleen Sereda | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 26, 2022 | May 31, 2022 | Elling Christian E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 26, 2022 | May 31, 2022 | Nielsen Jack | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 13, 2022 | Burkavage Brian | Chief Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 1, 2022 | Mar 3, 2022 | Smith David V | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 3, 2022 | Smith David V | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 9, 2021 | Nov 12, 2021 | HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | Buy | 100.0 | +325,000 | 13.74% | ✗ | $4.6M |
| Nov 9, 2021 | Nov 12, 2021 | Malier Vanessa | Director | Buy | 100.0 | +325,000 | 30.54% | ✗ | $4.6M |
| Nov 9, 2021 | Nov 12, 2021 | Vivo Capital IX, LLC | 10% Owner | Buy | 100.0 | +650,000 | 27.48% | ✗ | $9.1M |
| Nov 9, 2021 | Nov 12, 2021 | Andersson Claus A. | Director | Buy | 92.5 | +75,000 | 4.37% | ✗ | $1.1M |
| Nov 9, 2021 | Nov 12, 2021 | Zocca Mai-Britt | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 9, 2021 | Nov 12, 2021 | Lundbeckfond Invest A/S | 10% Owner | Buy | 100.0 | +2,142,857 | 54.85% | ✗ | $30M |
| Nov 9, 2021 | Nov 12, 2021 | Nielsen Jack | Director | Buy | 100.0 | +650,000 | 27.48% | ✗ | $9.1M |
| Nov 9, 2021 | Nov 10, 2021 | Novo Holdings A/S | 10% Owner | Buy | 100.0 | +325,000 | 11.01% | ✗ | $4.6M |
| Nov 4, 2021 | Nov 8, 2021 | Glaub Kathleen Sereda | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 4, 2021 | Nov 8, 2021 | Vendola Keith A. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 4, 2021 | Nov 8, 2021 | Hirth Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 4, 2021 | Nov 8, 2021 | Zocca Mai-Britt | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 4, 2021 | HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Zocca Mai-Britt | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Al-Hajj Muhammad | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Vivo Capital IX, LLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Vendola Keith A. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Nielsen Jack | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Malier Vanessa | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Lundbeckfond Invest A/S | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Hirth Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Glaub Kathleen Sereda | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Elling Christian E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Ehrnrooth Eva | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Coutanceau Emmanuelle | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Belawat Priyanka | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Andersson Claus A. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Novo Holdings A/S | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |